Practice guidelines for prenatal and perinatal immunohematology, revisited
dc.contributor.author | Judd, W. John | en_US |
dc.date.accessioned | 2010-06-01T20:40:23Z | |
dc.date.available | 2010-06-01T20:40:23Z | |
dc.date.issued | 2001-11 | en_US |
dc.identifier.citation | Judd, W. John (2001). "Practice guidelines for prenatal and perinatal immunohematology, revisited." Transfusion 41(11): 1445-1452. <http://hdl.handle.net/2027.42/73778> | en_US |
dc.identifier.issn | 0041-1132 | en_US |
dc.identifier.issn | 1537-2995 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73778 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11724993&dopt=citation | en_US |
dc.format.extent | 86749 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Inc | en_US |
dc.rights | 2001 American Association of Blood Banks | en_US |
dc.subject.other | CLT = Chemiluminescence Test | en_US |
dc.subject.other | FMH = Feto-maternal Hemorrhage | en_US |
dc.subject.other | MMA = Monocyte Monolayer Assay | en_US |
dc.subject.other | RhIg = Rh Immune Globulin | en_US |
dc.subject.other | SSCC = Scientific Section Coordinating Committee. | en_US |
dc.title | Practice guidelines for prenatal and perinatal immunohematology, revisited | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | From the Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan. | en_US |
dc.identifier.pmid | 11724993 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73778/1/j.1537-2995.2001.41111445.x.pdf | |
dc.identifier.doi | 10.1046/j.1537-2995.2001.41111445.x | en_US |
dc.identifier.source | Transfusion | en_US |
dc.identifier.citedreference | Judd WJ, Luban NLC, Ness PM, et al. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion 1990; 30: 175 83. | en_US |
dc.identifier.citedreference | Queenan JT, Tomai TP, Ural SH, King JC. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management. Am J Obstet Gynecol 1993; 168: 1370 6. | en_US |
dc.identifier.citedreference | 3. Prevention of hemolytic disease of the newborn due to anti-D. Association Bulletin 98-2. Bethesda: AABB, February 16, 1998. | en_US |
dc.identifier.citedreference | Vengelen-Tyler V, ed.. Technical manual. 13th ed. Bethesda: American Association of Blood Banks, 1999. | en_US |
dc.identifier.citedreference | Menitove JE, ed.. Standards for blood banks and transfusion services. 19th ed. Bethesda: American Association of Blood Banks, 1999. | en_US |
dc.identifier.citedreference | Sebring ES, Polesky HF. Detection of fetal maternal hemorrhage in Rh immune globulin candidates. A rosetting technique using enzyme-treated Rh 2 Rh 2 indicator erythrocytes. Transfusion 1982; 22: 468 71. | en_US |
dc.identifier.citedreference | Butch SH, Judd WJ. Simplified protocol for screening Rh immune globulin candidates (abstract). Transfusion 1983; 23: 440. | en_US |
dc.identifier.citedreference | Lubenko A, Contreras M, Habash J. Should anti-Rh immunoglobulin be given to D variant women? Br J Haematol 1989; 72: 429 33. | en_US |
dc.identifier.citedreference | Wagner FF, Kasulke D, Kerowgan M, Flegel WA. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany. Infusionsther Transfusionsmed 1995; 22: 285 90. | en_US |
dc.identifier.citedreference | Bowman JM, Chown B, Lewis M, Pollock JM. Rh isoimmunization during pregnancy: antenatal prophylaxis. CMAJ 1978; 118: 623 7. | en_US |
dc.identifier.citedreference | 11. Clinical management for obstetricians-gynecologists. ACOG Practice Bulletin Number 4. Washington: American College of Obstetricians and Gynecologists, 1999. | en_US |
dc.identifier.citedreference | Rothenberg JM, Weirermiller B, Dirig K, et al. Is a third-trimester antibody screen in Rh+ women necessary? Am J Manag Care 1999; 5: 1145 50. | en_US |
dc.identifier.citedreference | Heddle NM, Klama L, Frassetto R, et al. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy. Transfusion 1993; 23: 217 20. | en_US |
dc.identifier.citedreference | Shulman IA, Calderon C, Nelson JM, Nakayama R. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies. Transfusion 1994; 34: 666 70. | en_US |
dc.identifier.citedreference | Reid ME, Chandrasekaran V, Sausais L, et al. Disappearance of antibodies to Cromer blood group system antigens during mid pregnancy. Vox Sang 1996; 71: 48 50. | en_US |
dc.identifier.citedreference | Smith ML, Beck ML. The immunoglobulin structure of human anti-M agglutinins. Transfusion 1979; 19: 472 4. | en_US |
dc.identifier.citedreference | Reid ME, Lomas-Francis C. The blood group antigen FactsBook. San Diego: Academic Press, 1997: 32. | en_US |
dc.identifier.citedreference | Bowman JM, Pollock JM. Amniotic fluid spectrophotometry and early delivery in the management of erythroblastosis fetalis. Pediatrics 1965; 35: 815 9. | en_US |
dc.identifier.citedreference | Weiner CP, Williamson RA, Wenstrom KD, et al. Management of fetal hemolytic disease by cordocentesis. I. Prediction of fetal anemia. Am J Obstet Gynecol 1991; 165: 546 53. | en_US |
dc.identifier.citedreference | Wade RV. Images, imagination and ideas: a perspective on the impact of ultrasonography on the practice of obstetrics and gynecology. Presidential address. Am J Obstet Gynecol 1999; 181: 235 9. | en_US |
dc.identifier.citedreference | Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000; 342: 9 14. | en_US |
dc.identifier.citedreference | Queenan JT. Modern management of the Rh problem. 2nd ed. Hagerstown, MD: Harper and Row, 1977. | en_US |
dc.identifier.citedreference | Freda VJ. The Rh problem in obstetrics and a new concept of its management using amniocentesis and spectrophotometric scanning of amniotic fluid. Am J Obstet Gynecol 1965; 92: 341 74. | en_US |
dc.identifier.citedreference | Sazama K. Comprehensive transfusion medicine survey J-C, final critique. Chicago: College of American Pathologists, 1995. | en_US |
dc.identifier.citedreference | Lapierre Y, Rigal D, Adam J, et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990; 30: 109 13. | en_US |
dc.identifier.citedreference | Spinnato JA. Hemolytic disease of the fetus: a plea for restraint. Obstet Gynecol 1992; 80: 873 7. | en_US |
dc.identifier.citedreference | Goodrick MJ, Hadley AG, Poole G. Haemolytic disease of the fetus and newborn due to anti-Fy a and the potential clinical value of Duffy genotyping in pregnancies at risk. Transfus Med 1997; 7: 301 4. | en_US |
dc.identifier.citedreference | Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798 803. | en_US |
dc.identifier.citedreference | Shirey RS, Mirabella DC, Lumadue JA, Ness PM. Differentiation of anti-D, -C, and -G: clinical relevance in alloimmunized pregnancies. Transfusion 1997; 37: 493 6. | en_US |
dc.identifier.citedreference | Judd WJ. Methods in immunohematology. 2nd ed. Durham, NC: Montgomery Scientific Publications, 1994. | en_US |
dc.identifier.citedreference | Van Dijk BA, Dooren MC, Overbeeke MA. Red cell antibodies in pregnancy: there is no critical titre. Transfus Med 1995; 5: 199 202. | en_US |
dc.identifier.citedreference | Engelfreit CP, Reesink HW, Bowman J, et al. Laboratory procedures for the prediction of the severity of haemolytic disease of the newborn. Vox Sang 1995; 69: 61 9. | en_US |
dc.identifier.citedreference | Lucas GF, Hadley AG, Nance SJ, Garratty G. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993; 33: 484 7. | en_US |
dc.identifier.citedreference | Sacks DA, Nance SJ, Garratty G, et al. Monocyte monolayer assay as a predictor of severity of hemolytic disease of the fetus and newborn. Am J Perinatol 1993; 10: 428 31. | en_US |
dc.identifier.citedreference | Hadley AG, Wilkes A, Goodrick J, et al. The ability of the chemiluminescence test to predict clinical outcome and the necessity for amniocenteses in pregnancies at risk of haemolytic disease of the newborn. Br J Obstet Gynaecol 1998; 105: 231 4. | en_US |
dc.identifier.citedreference | Bowman JM. Hemolytic disease of the newborn. Vox Sang 1996; 70: 62 7. | en_US |
dc.identifier.citedreference | Oepkes D van Kemp IL, Simon MJG, et al. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization. Am J Obstetr Gynecol 2001; 184: 1015 20. | en_US |
dc.identifier.citedreference | Avent ND, Finning KM, Martin PG, Soothill PW. Prenatal determination of fetal blood group status. Vox Sang 2000; 78: 155 62. | en_US |
dc.identifier.citedreference | Van Den Veyver IB, Subramanian SB, Hudson KM, et al. Prenatal diagnosis of the RhD fetal blood type on amniotic fluid by polymerase chain reaction. Obstet Gynecol 1996; 87: 419 22. | en_US |
dc.identifier.citedreference | Ness PM, Salamon JL. The failure of postinjection Rh immune globulin titers to detect large fetal-maternal hemorrhages. Am J Clin Pathol 1986; 85: 604 6. | en_US |
dc.identifier.citedreference | Kleihauer E, Betke K. [Practical application of the detection of HbF-containing cells in fixed blood smears]. Internist 1960; 1: 292 6. | en_US |
dc.identifier.citedreference | Lubenko A, Williams M, Johnson A, et al. Monitoring the clearance of fetal RhD-positive red cells in FMH following RhD immunoglobulin administration. Transfus Med 1999; 9: 331 5. | en_US |
dc.identifier.citedreference | Riley JZ, Ness PM, Taddie SJ, et al. Detection and quantitation of fetal maternal hemorrhage utilizing an enzyme-linked antiglobulin test. Transfusion 1982; 22: 472 4. | en_US |
dc.identifier.citedreference | 44. Practice parameter: management of hyperbiliruinemaia in the healthy term newborn. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Pediatrics 1994; 94: 558 65. | en_US |
dc.identifier.citedreference | 45. Joint Commission on Accreditation of Healthcare Organizations, Sentinel Event Alert. Issue 18: Kernicterus threatens healthy newborns. April 2001: ( http://www.jcaho.org/edupub/sealert/sea18.html ). | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.